Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. [electronic resource]
Producer: 20021016Description: 229-37 p. digitalISSN:- 1045-4411
- Adjuvants, Immunologic -- pharmacology
- Antigens -- immunology
- Antigens, Surface -- immunology
- B7-1 Antigen -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cell Death -- immunology
- Cell Survival -- immunology
- Chemokines -- antagonists & inhibitors
- Cytokines -- antagonists & inhibitors
- DNA-Binding Proteins -- immunology
- Early Growth Response Protein 2
- Fas Ligand Protein
- Humans
- Immunity, Active -- immunology
- Immunity, Innate -- immunology
- Inducible T-Cell Co-Stimulator Ligand
- Inflammation Mediators -- antagonists & inhibitors
- Interleukin-10 -- biosynthesis
- Macrophage Activation -- immunology
- Membrane Glycoproteins -- immunology
- NF-kappa B -- immunology
- NFATC Transcription Factors
- Neuropeptides -- immunology
- Nitric Oxide -- antagonists & inhibitors
- Nuclear Proteins
- Pituitary Adenylate Cyclase-Activating Polypeptide
- Shock, Septic -- immunology
- T-Lymphocytes -- immunology
- T-Lymphocytes, Helper-Inducer -- immunology
- Th2 Cells -- immunology
- Transcription Factors -- genetics
- Vasoactive Intestinal Peptide -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.